From the original article | From FumaClub
An astonishing $8 billion jury verdict against Johnson & Johnson this week was not just a potent rebuke of the prescription drug giant’s conduct but also represented what some analysts Wednesday called a symptom of a growing anger at the broader pharmaceutical industry.
(NOTE: This article was before COVID). The attitude toward the pharmaceutical industry hasn’t been quite the same since people found out they were largely behind smoking bans. But now this?
The remainder of this post is for members only. $2 gets you unlimited access to all posts, including hidden, members-only posts, as well as images, videos, data and various other resources.
FumaClub 